Pivotal trials of PTX in ovarian cancer addressed its role as a single agent in heavily pre-treated patients with refractory disease when administered in a dose of 135 mg/m 2 every 3 weeks upon intolerance or progression
Multi-dose vial format designed for repeated withdrawals using appropriate sterile technique
doi: 10.1007/s10753-011-9310-z 149
Prog Neuro-Psychopharmacol Biol Psychiatry 88:352359 Eshraghi R, Deth RC, Mittal R, Aranke M, Kay S-IS, Moshiree B, Eshraghi A (2018) Early disruption of the microbiome leading to decreased antioxidant capacity and epigenetic changes: implications for the rise in autism
Regulatory status can change over time
Inflammation demystified: An in-depth comprehensive review Department of Pharmacy, Faculty of Pharmacy, Integral University, Lucknow, Uttar Pradesh, India-226026 Abstract The immune system responds to viral pathogens, damaged cells, and diverse irritants through a complex, highly regulated biochemical cascade known as inflammation